NIH, NIST researchers use artificial intelligence for quality control of stem cell-derived tissues
National Institutes of Health (NIH) sent this bulletin at 11/14/2019 01:30 PM ESTHaving trouble viewing this email? View it as a Web page.
You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).
11/14/2019 12:30 PM EST
Technique key to scale up manufacturing of therapies from induced pluripotent stem cells.